It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

“The Afib Symposium held in Paris is an educational event sponsored by Biosense Webster, a division of Johnson & Johnson Medical NV/SA. This link provides access to sessions presented during this educational event. The broadcasting and presentations on the following pages are only intended for Biosense Webster’s employees and HealthCare Professionals in Europe. It is only available in English language. By accessing to the present webpage you are confirming that you are a healthcare professional in Europe-Middle East and Africa where English is accepted.
The material contained in this session reflects the techniques, drug dosage, approaches and opinions of the individual presenter(s). This Biosense Webster, a division of Johnson & Johnson Medical NV/SA sponsored presentation may include demonstration of the use of medical devices; it is not intended to be used as a medical training guide. The steps demonstrated may not be the complete steps of the procedure. Before using any medical device, including those demonstrated or referenced in this presentation, review all relevant package inserts, with particular attention to the indications, contraindications, warnings and precautions, and steps for use of the device.
Always verify catheter tip location using fluoroscopy or IC signals and consult the CARTO® System User Guide regarding recommendations for fluoroscopy use. Catheter advancement should be done under fluoroscopic guidance. Do not use excessive force to advance or withdraw the catheter when resistance is encountered. Careful catheter manipulation must be performed in order to avoid cardiac damage, perforation, or tamponade.
RF parameters you may find in this session provide conceptual information that does not intent to reflect parameters used in clinical practice (such as Power, impedance, temperature, contact force). Refer to relevant user manual and to clinical practice for recommended parameters.
The third party trademarks used herein are trademarks of their respective owners.
All content of this presentation is owned by their authors and is protected by worldwide copyright laws.”

8.30 - 9.00 - Introduction

Chairs R. Schilling - London, UK • J. Kautzner - Prague, CZ  
8.30 - 8.50 Is atrial fibrillation a risk marker or a risk factor for stroke? J. Camm - London, UK

9.00 - 10.30 - Session 1: Substrate-directed Catheter Ablation

Chairs I. Deisenhofer - Munich, DE • J. Seitz - Marseille, FR  
Moderator K.-H. Kuck - Hamburg, DE  
9.00 - 9.15 Ablation guided by focal impulse and rotor mapping S. Narayan - San Diego, USA
9.15 - 9.30 Ablation guided by body surface mapping M. Haïssaguerre - Bordeaux, FR
9.30 - 9.45 Ablation guided by low-voltage mapping H. Kottkamp - Zurich, CH
9.45 - 10.00 Commentary U. Schotten - Maastricht, NL

11.00 - 12.15 - Session 2: Role of Pulmonary Vein Isolation (PVI) in Persistent AF

Chairs C. de Chillou - Nancy, FR • P. Adragao - Lisbon, PT  
Moderator J. Chen - Bergen, NO  
11.00 - 11.15 Outcome after repeated PVI in persistent AF R. Tilz - Hamburg, DE
11.15 - 11.30 Adjunctive effect of defractionation and/or lines A. Verma - Newmarket, CA

13.15 - 14.45 - Session 3: Surgical Approaches for Atrial Fibrillation

Chairs E. Pokushalov - Novosibirsk, RU • T. De Potter - Aalst, BE  
Moderator N. Doll - Stuttgart, DE  
13.15 - 13.30 Indications and long term results B. Maesen - Maastricht, NL
13.30 - 13.45 Insights from intra-operative mapping in AF N. de Groot - Rotterdam, NL
13.45 - 14.00 Mapping directed surgical ablation T. Nitta - Tokyo, JP
14.00 - 14.15 Staged thoracoscopic and endocardial ablation B. van Putte - Utrecht, NL

15.15 - 16.45 - Session 4: Challenging AF Subgroups

Chairs T. Gaspar - Dresden, DE • M. G. Bongiorni - Pisa, IT  
Moderator J. Kautzner - Prague, CZ  
15.15 - 15.30 The asymptomatic patient H. Pürerfellner - Linz, AT
15.45 - 16.00 AF in channelopathies P. Lambiase - London, UK
16.00 - 16.15 Heart failure with preserved and reduced Ejection Fraction R. Schilling - London, UK

16.45 - 17.25 - Session 5: The Five Studies of the Last 12 Months with the Greatest Influence on My Practice

Chairs T. Arentz - Bad Krozingen, DE • H. Nakagawa - Oklahoma City, USA  
16.45 - 17.05 The interventional studies of the last 12 months with the greatest influence on my practice V. Reddy - New York, USA
17.05 - 17.25 The non-interventional studies of the last 12 months with the greatest influence on my practice P. Lambiase - London, UK

8.15 - 9.45 - Session 6: Lesion Creation and Assessment

Chairs H. K. Jensen - Aarhus, DK • A. Sarkozy - Antwerp, BE  
Moderator D. Gupta - Liverpool, UK  
8.15 - 8.30 Biophysics and thermodynamics of lesion formation D. Haines - Royal Oak, USA
8.45 - 9.00 Insights from real-time Ultrasound visualisation of lesions M. Wright - London, UK
9.00 - 9.15 Insights from MRI visualisation of lesions M. O'Neill - London, UK

9.45 - 10.45 - Session 7: Complications in AF Ablations - Unresolved Issues and Decision Making

Chairs C. de Chillou - Nancy, FR • M. O’Neill - London, UK  
9.45 - 10.00 Refractory hypotension and tamponade during procedure R. Cappato - San Donato Milanese, IT
10.00 - 10.15 Breathlessness after catheter ablation L. Di Biase - New-York, USA
10.15 - 10.30 Oesophageal injury to fistula: Mechanisms & Management P. Müller - Bad Neustadt, DE

11.15 - 13.00 - Session 8: The PVI Toolbox

Chairs C. Tondo - Milan, IT • J.-P. Albenque - Toulouse, FR  
Moderators P. Jaïs - Bordeaux, FR  
11.15 - 11.30 What is relevant when choosing a PVI tool? H. Kottkamp - Zurich, CH
11.30 - 11.45 Individualised lesion optimisation M. Duytschaever - Brugge, BE
11.45 - 12.00 Circular multi - electrode based PVI A. Ng - Leiceister, UK
12.00 - 12.15 Balloon based PVI B. Schmidt - Frankfurt, DE
12.15 - 12.30 Emerging technologies in PVI K.-H. Kuck - Hamburg, DE


Scroll Up